EXHIBIT 99.7
Consent to be Named as a Director Nominee
In connection with the filing by Bellevue Life Sciences Acquisition Corp. (the Company) of the Registration Statement on Form S-1 with the US Securities and Exchange Commission under the Securities Act of 1933, as amended (the Securities Act), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the Board of Directors of the Company in the Registration Statement and any and all amendments and supplements thereto.
I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
/s/ Jin Whan Park |
Jin Whan Park |
Dated: October 7, 2022